Nature Microbiology

Attention for neglected pathogens

Zika virus and melioidosis hit the news

Go to the profile of Nonia Pariente
Jan 12, 2016
6
0

Public awareness of emergent pathogens has turned in recent hours to two threats perceived as new: Zika virus and Burkholderia pseudomallei. Both mainstream news and social media have taken note of a case of Zika virus infection diagnosed in Texas yesterday and a study published by Nature Microbiology on the predicted distribution of B. pseudomallei and the burden of melioidosis worldwide.

It is nice to see these pathogens having a place in the news cycle (for example here, here and here), which should draw attention and hopefully much needed funding for research into these areas. Of course, for us at @NatureMicrobiol, it is great to see that one of our articles garners so much press. For additional information on Zika virus, you can go here and here, and on meloidosis, this prescient Nature Reviews Microbiology Review is really nice.

Go to the profile of Nonia Pariente

Nonia Pariente

Senior Editor, Nature Microbiology

I come from a mid-sized city on the northwestern coast of Spain. My interest in science initially took me to Madrid, where I finished university and received a PhD in molecular biology. In Madrid, I studied RNA virus evolution and new antiviral strategies with Esteban Domingo. I then moved to UCLA, where I focused on developing lentiviral vectors for gene therapy in Irvin Chen’s laboratory. In 2007, I made the plunge from bench to desk and joined the EMBO Reports editorial team as Reviews Editor, becoming Scientific Editor two years later and Senior Editor in 2012. At EMBO Reports, I was responsible for microbiology and immunology, among other areas, and spent many years expanding my understanding and love for all things microbial. At Nature Microbiology, I handle all things related to virology and mycology, and look forward to interacting with the community and providing a venue to publish the most important advances in the field.

No comments yet.